Supplementary Figures from Inhibiting DX2-p14/ARF Interaction Exerts Antitumor Effects in Lung Cancer and Delays Tumor Progression

Supplemental Figure S1. The effect of oncogenes on DX2 expression. Supplemental Figure S2. Oncogenic property of DX2. Supplemental Figure S3. Small cell lung cancer in DX2 and DK transgenic model. Supplemental Figure S4. DX2 suppresses p14/ARF. Supplemental Figure S5. Screening of specific inhibitor of p14/ARF and DX2. Supplemental Figure S6. SLCB050 as specific binding inhibitor of p14/ARF and DX2. Supplemental Figure S7. The effect of SLCB050 on DX2. Supplemental Figure S8. Anti-tumoral effects of SLCB050 in DK mice. Supplemental Figure S9. Diagram for summary.